In the UK, non-diabetic hyperglycaemia (NDH, sometimes called 'prediabetes') affects a significant proportion of adults, with many remaining undiagnosed
N-acetylcysteine (NAC), a glutathione precursor, carries less than 5% constipation risk because it converts to glutathione intracellularly after absorption, avoiding direct gut lumen interaction
Although the favourable effect of tirzepatide on this endpoint appeared to be predominantly driven by a reduction in new onset macroalbuminuria [22], it is worth noting that the differences in changes in albuminuria during the time course of the study were mainly attributable to a progressive increase in the insulin glargine group whereas levels remained relatively stable in the tirzepatide-treated group
If you get Medicare drug coverage, you may become eligible
Tirzepatide acts on two pathways (GLP1 and GIP), while semaglutide targets GLP1